ZNTL Zentalis Pharmaceuticals, Inc. - common stock
$3,59
Prix · Mai 20, 2026
Données fondamentales au Mai 12, 2026
Fourchette 52 semaines
$1–$7
42% of range
Note des analystes
HOLD
15 analysts
Objectif de cours
$6
+81% upside
P/E (TTM)
-0.7
ROE
-49.5%
Marge nette
—
ZNTL Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$3.58
Capitalisation Boursière
$93M
P/E (TTM)
-0.7
BPA (TTM)
$-1.91
Revenus (TTM)
$0
Rendement div.
—
ROE
-49.5%
Dette/Capitaux propres
—
Fourchette 52 semaines
$1 – $7
ZNTL Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$0
2022-12-31
→
2025-12-31
BPA
$-1.91
2019-12-31
→
2025-12-31
Flux de trésorerie libre
$-125M
2020-12-31
→
2025-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
ZNTL
Médiane des pairs
P/E (TTM)
-0.7
8.1
P/B
0.4
1.6
Price / FCF (Cours / FCF)
-0.7
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
ZNTL
Médiane des pairs
ROA
-38.1%
-40.5%
ROE
-49.5%
-52.8%
ROIC
-70.9%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
ZNTL
Médiane des pairs
Current Ratio (Ratio de liquidité)
6.9
5.8
Quick Ratio (Ratio de liquidité réduite)
1.0
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
ZNTL
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
ZNTL
Médiane des pairs
ZNTL Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
15 analystes
- Achat fort 4 26,7%
- Achat 5 33,3%
- Conserver 6 40,0%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
8 analystes · 2026-05-19
Médiane
$5.50
Moyenne
$6.50
← En dessous de tous les objectifs
$3.58
Bas
$4.00
Haut
$10.00
Objectif médian
$5.50
+53,4%
Objectif moyen
$6.50
+81,3%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.11%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.50 | $-0.49 | -0.01% |
| 31 décembre 2025 | $-0.50 | $-0.59 | 0.09% |
| 30 septembre 2025 | $-0.37 | $-0.54 | 0.17% |
| 30 juin 2025 | $-0.37 | $-0.59 | 0.22% |
| 31 mars 2025 | $-0.56 | $-0.65 | 0.09% |
| 31 décembre 2024 | $-0.62 | $-0.72 | 0.10% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| ZNTL | $93M | -0.7 | — | — | -49.5% | — |
| ALXO | $61M | -0.6 | — | — | -225.0% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| AVXL | $771M | -16.5 | -36.1% | -991.4% | -47.7% | — |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | — |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $67M | $0 | $0 | |
| R&D Expense | $107M | $168M | $190M | $173M | |
| SG&A Expense | $38M | $87M | $64M | $55M | |
| Operating Expenses | $153M | $259M | $300M | $227M | |
| Operating Income | $-153M | $-191M | $-300M | $-227M | |
| Pretax Income | $-137M | $-166M | $-293M | $-238M | |
| Income Tax | $442.0K | $177.0K | $-601.0K | $-469.0K | |
| Net Income | $-137M | $-166M | $-292M | $-237M | |
| EPS (Basic) | $-1.91 | $-2.33 | $-4.47 | $-4.48 | |
| EPS (Diluted) | $-1.91 | $-2.33 | $-4.47 | $-4.48 | |
| Shares (Basic) | 71,869,000 | 71,080,000 | 65,409,000 | 52,857,000 | |
| Shares (Diluted) | 71,869,000 | 71,080,000 | 65,409,000 | 52,857,000 | |
| EBITDA | $-152M | $-190M | $-298M | $-226M |
Bilan 23
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $36M | $34M | $28M | $43M | |
| Receivables | $0 | $5M | $0 | · | |
| Prepaid Expense | $7M | $10M | $14M | $15M | |
| Current Assets | $253M | $386M | $497M | $452M | |
| PP&E (Net) | $3M | $5M | $6M | $8M | |
| PP&E (Gross) | $6M | $9M | $9M | $10M | |
| Accum. Depreciation | $3M | $4M | $3M | $2M | |
| Goodwill | · | $0 | $4M | $4M | |
| Total Assets | $289M | $430M | $552M | $539M | |
| Accounts Payable | $7M | $7M | $15M | $11M | |
| Accrued Liabilities | $29M | $45M | $54M | $45M | |
| Current Liabilities | $37M | $53M | $69M | $57M | |
| Capital Leases | $36M | $40M | $43M | $45M | |
| Deferred Tax | · | · | $0 | $853.0K | |
| Other Non-current Liabilities | $500.0K | $849.0K | $2M | $3M | |
| Total Liabilities | $73M | $93M | $114M | $105M | |
| Common Stock | $69.0K | $71.0K | $70.0K | $59.0K | |
| Paid-in Capital | $1.41B | $1.39B | $1.32B | $1.03B | |
| Retained Earnings | $-1.19B | $-1.05B | $-889M | $-596M | |
| AOCI | $196.0K | $558.0K | $2M | $-1M | |
| Stockholders' Equity | $216M | $337M | $437M | $434M | |
| Liabilities + Equity | $289M | $430M | $552M | $539M | |
| Shares Outstanding | 69,085,980 | 71,282,000 | 70,767,000 | 59,280,000 |
Flux de trésorerie 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $739.0K | $1M | $1M | $1M | |
| Stock-based Comp | $21M | $67M | $55M | $47M | |
| Deferred Tax | $51.0K | $-63.0K | $-891.0K | $-778.0K | |
| Restructuring | $8M | $0 | $0 | · | |
| Other Non-cash | $-10M | $-74M | $29M | $26M | |
| Operating Cash Flow | $-125M | $-171M | $-208M | $-164M | |
| CapEx | $0 | $221.0K | $583.0K | $3M | |
| Investing Cash Flow | $132M | $177M | $-44M | $-114M | |
| Stock Issued | $5M | $0 | $236M | $258M | |
| Stock Repurchased | $10M | $0 | $0 | · | |
| Net Stock Activity | $-5M | $0 | $236M | $258M | |
| Financing Cash Flow | $-4M | $108.0K | $237M | $261M | |
| Net Change in Cash | $2M | $6M | $-15M | $-17M | |
| Taxes Paid | $85.0K | · | · | · | |
| Free Cash Flow | $-125M | $-171M | $-208M | $-166M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | · | -283.6% | · | · | |
| Net Margin | · | -246.0% | · | · | |
| Pretax Margin | · | -245.7% | · | · | |
| EBITDA Margin | · | -281.6% | · | · | |
| ROA | -38.1% | -33.8% | -53.6% | -47.7% | |
| ROE | -49.5% | -42.8% | -67.1% | -59.3% | |
| ROIC | -70.9% | -56.8% | -68.3% | -52.3% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 6.9 | 7.3 | 7.2 | 8.0 | |
| Quick Ratio | 1.0 | 0.7 | 0.4 | 0.8 |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | · | |
| Receivables Turnover | 0.0 | 27.0 | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $0 | $67M | $0 | $0 | |
| Net Income TTM | $-137M | $-166M | $-292M | $-237M | |
| Market Cap | $93M | $216M | $1.07B | $1.19B | |
| P/E | -0.7 | -1.3 | -3.4 | -4.5 | |
| P/S | · | 3.2 | · | · | |
| P/B | 0.4 | 0.6 | 2.5 | 2.8 | |
| P / Tangible Book | 0.4 | 0.6 | 2.5 | 2.8 | |
| P / Cash Flow | -0.7 | -1.3 | -5.2 | -7.3 | |
| P / FCF | -0.7 | -1.3 | -5.1 | -7.2 | |
| Earnings Yield | -141.5% | -76.9% | -29.5% | -22.2% |
Compte de résultat 13
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $0 | $0 | $0 | $0 | $27M | $0 | $0 | $41M | $0 | $0 | $0 | $0 | |
| R&D Expense | $29M | $29M | $23M | $28M | $27M | $33M | $37M | $48M | $50M | $52M | $47M | $43M | $49M | |
| SG&A Expense | $9M | $8M | $11M | $8M | $11M | $40M | $15M | $17M | $16M | $16M | $16M | $16M | $16M | |
| Operating Expenses | $38M | $37M | $34M | $36M | $46M | $77M | $51M | $65M | $65M | $68M | $63M | $104M | $65M | |
| Operating Income | $-38M | $-37M | $-34M | $-36M | $-46M | $-50M | $-51M | $-65M | $-25M | $-68M | $-63M | $-104M | $-65M | |
| Pretax Income | $-35M | $-35M | $-27M | $-27M | $-48M | $-48M | $-40M | $-88M | $10M | $-77M | $-56M | $-99M | $-61M | |
| Income Tax | $120.0K | $442.0K | $0 | $0 | $0 | $-205.0K | $-27.0K | $266.0K | $143.0K | $-135.0K | $31.0K | $-605.0K | $108.0K | |
| Net Income | $-35M | $-35M | $-27M | $-27M | $-48M | $-47M | $-40M | $-88M | $10M | $-61M | $-56M | $-113M | $-63M | |
| EPS (Basic) | $-0.50 | $-0.50 | $-0.37 | $-0.37 | $-0.67 | $-0.67 | $-0.56 | $-1.24 | $0.14 | $-0.76 | $-0.79 | $-1.85 | $-1.07 | |
| EPS (Diluted) | $-0.50 | $-0.50 | $-0.37 | $-0.37 | $-0.67 | $-0.67 | $-0.56 | $-1.24 | $0.14 | $-0.76 | $-0.79 | $-1.85 | $-1.07 | |
| Shares (Basic) | 70,264,000 | -143,940,000 | 72,139,000 | 71,992,000 | 71,678,000 | -141,969,000 | 71,111,000 | 71,040,000 | 70,898,000 | -125,270,000 | 70,612,000 | 60,790,000 | 59,277,000 | |
| Shares (Diluted) | 70,264,000 | -143,940,000 | 72,139,000 | 71,992,000 | 71,678,000 | -142,263,000 | 71,111,000 | 71,040,000 | 71,192,000 | -125,270,000 | 70,612,000 | 60,790,000 | 59,277,000 | |
| EBITDA | $-38M | · | $-34M | $-36M | $-45M | · | $-51M | $-65M | $-24M | · | $-62M | $-104M | $-65M |
Bilan 23
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $36M | $39M | $38M | $42M | $34M | $41M | $37M | $38M | $28M | $111M | $267M | $36M | |
| Receivables | · | $0 | $0 | $0 | $0 | $5M | · | · | · | · | · | · | · | |
| Prepaid Expense | $6M | $7M | $8M | $8M | $10M | $10M | $9M | $13M | $15M | · | $12M | $11M | $18M | |
| Current Assets | $218M | $253M | $288M | $312M | $343M | $386M | $400M | $440M | $504M | · | $528M | $564M | $410M | |
| PP&E (Net) | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $6M | · | $6M | $7M | $7M | |
| PP&E (Gross) | $6M | $6M | $6M | $6M | $6M | $9M | $9M | $9M | $9M | · | $10M | $9M | $10M | |
| Accum. Depreciation | $3M | $3M | $3M | $3M | $2M | $4M | $4M | $4M | $3M | · | $3M | $3M | $3M | |
| Goodwill | · | · | · | · | · | · | $4M | $4M | $4M | · | $4M | $4M | $4M | |
| Total Assets | $253M | $289M | $327M | $352M | $384M | $430M | $451M | $492M | $557M | · | $586M | $621M | $489M | |
| Accounts Payable | $7M | $7M | $7M | $4M | $8M | $7M | $8M | $20M | $11M | · | $14M | $12M | $13M | |
| Accrued Liabilities | $28M | $29M | $30M | $35M | $42M | $45M | $47M | $46M | $44M | · | $45M | $39M | $44M | |
| Current Liabilities | $35M | $37M | $37M | $39M | $49M | $53M | $55M | $67M | $55M | · | $59M | $52M | $56M | |
| Capital Leases | $35M | $36M | $37M | $38M | $39M | $40M | $40M | $41M | $43M | · | $43M | $44M | $45M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $756.0K | |
| Other Non-current Liabilities | $500.0K | $500.0K | $500.0K | $500.0K | $558.0K | $849.0K | $996.0K | $1M | $1M | · | $2M | $2M | $2M | |
| Total Liabilities | $70M | $73M | $74M | $77M | $89M | $93M | $96M | $109M | $99M | · | $104M | $98M | $104M | |
| Common Stock | $71.0K | $69.0K | $72.0K | $72.0K | $72.0K | $71.0K | $71.0K | $71.0K | $70.0K | · | $70.0K | $70.0K | $59.0K | |
| Paid-in Capital | $1.41B | $1.41B | $1.41B | $1.40B | $1.40B | $1.39B | $1.36B | $1.35B | $1.34B | · | $1.31B | $1.30B | $1.05B | |
| Retained Earnings | $-1.23B | $-1.19B | $-1.16B | $-1.13B | $-1.10B | $-1.05B | $-1.01B | $-967M | $-878M | · | $-828M | $-772M | $-660M | |
| AOCI | $-50.0K | $196.0K | $186.0K | $59.0K | $358.0K | $558.0K | $2M | $140.0K | $773.0K | · | $-359.0K | $-338.0K | $-556.0K | |
| Stockholders' Equity | $183M | $216M | $253M | $274M | $295M | $337M | $354M | $383M | $459M | · | $482M | $523M | $385M | |
| Liabilities + Equity | $253M | $289M | $327M | $352M | $384M | $430M | $451M | $492M | $557M | · | $586M | $621M | $489M | |
| Shares Outstanding | 71,156,113 | 69,085,980 | 72,245,529 | 72,135,453 | 71,950,683 | 71,282,400 | 71,149,666 | 71,106,719 | 71,011,982 | 70,767,000 | 70,640,684 | 70,603,663 | 59,442,342 |
Flux de trésorerie 11
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $151.0K | $157.0K | $160.0K | $160.0K | $262.0K | $317.0K | $321.0K | $327.0K | $324.0K | $337.0K | $348.0K | $344.0K | $360.0K | |
| Stock-based Comp | $3M | $3M | $5M | $6M | $6M | $31M | $10M | $13M | $13M | $14M | $14M | $13M | $14M | |
| Restructuring | $0 | $0 | $0 | $0 | $8M | $0 | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | $-952.0K | · | · | · | $9M | · | · | · | $-75M | · | · | · | $-157.0K | |
| Operating Cash Flow | $-33M | $-31M | $-27M | $-35M | $-33M | $-40M | $-44M | $-35M | $-52M | $-41M | $-39M | $-79M | $-49M | |
| CapEx | $34.0K | $0 | $0 | $0 | $0 | $0 | $0 | $181.0K | $40.0K | $173.0K | $91.0K | $319.0K | $0 | |
| Investing Cash Flow | $30M | $32M | $28M | $30M | $40M | $32M | $48M | $34M | $62M | $-42M | $-117M | $73M | $42M | |
| Stock Issued | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $-1M | $-5M | $115.0K | $0 | $189.0K | $0 | $92.0K | $9.0K | $7.0K | $0 | $309.0K | $237M | $373.0K | |
| Net Change in Cash | $-4M | $-3M | $1M | $-4M | $8M | $-7M | $4M | $-640.0K | $10M | $-83M | $-156M | $230M | $-7M | |
| Free Cash Flow | $-33M | · | · | · | $-33M | · | · | · | $-52M | · | · | · | $-49M |
Rentabilité 7
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -61.1% | · | · | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | 24.8% | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | 25.1% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -60.3% | · | · | · | · | |
| ROA | -11.1% | · | -6.9% | -6.4% | -10.3% | · | -7.8% | -15.9% | 1.9% | · | -10.0% | -18.9% | -14.1% | |
| ROE | -14.8% | · | -8.8% | -8.2% | -12.8% | · | -9.6% | -19.5% | 2.4% | · | -12.2% | -22.6% | -18.0% | |
| ROIC | -20.8% | · | -13.3% | -13.1% | -15.4% | · | -14.5% | -17.1% | -5.3% | · | -13.0% | -19.7% | -16.9% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | · | 7.8 | 8.0 | 6.9 | · | 7.3 | 6.6 | 9.2 | · | 9.0 | 10.9 | 7.3 | |
| Quick Ratio | 0.9 | · | 1.1 | 1.0 | 0.8 | · | 0.8 | 0.6 | 0.7 | · | 1.9 | 5.2 | 0.6 |
Efficacité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | · | · | · | |
| Receivables Turnover | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | · | $0 | $0 | $41M | · | $41M | $41M | $41M | · | · | · | · | |
| Net Income TTM | $-137M | · | $-142M | $-204M | $-167M | · | $-174M | $-246M | $-221M | · | $-286M | $-299M | $-245M | |
| Market Cap | $167M | · | $109M | $84M | $114M | · | $262M | $291M | $1.12B | · | $1.42B | $1.99B | $1.02B | |
| P/E | -1.2 | · | -0.8 | -0.4 | -0.7 | · | -1.5 | -1.1 | -4.4 | · | -4.3 | -5.4 | -3.7 | |
| P/S | · | · | · | · | 2.8 | · | 6.5 | 7.2 | 27.6 | · | · | · | · | |
| P/B | 0.9 | · | 0.4 | 0.3 | 0.4 | · | 0.7 | 0.8 | 2.4 | · | 2.9 | 3.8 | 2.7 | |
| P / Tangible Book | 0.9 | · | 0.4 | 0.3 | 0.4 | · | 0.7 | 0.8 | 2.5 | · | 3.0 | 3.8 | 2.7 | |
| P / Cash Flow | -5.1 | · | · | · | -3.5 | · | · | · | -21.5 | · | · | · | -20.7 | |
| P / FCF | -5.0 | · | · | · | -3.5 | · | · | · | -21.5 | · | · | · | -20.7 | |
| Earnings Yield | -81.6% | · | -130.5% | -244.8% | -146.5% | · | -66.6% | -91.4% | -22.7% | · | -23.3% | -18.5% | -27.2% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $0 | $67M | $0 | $0 | — |
| Marge d'exploitation % | — | -283.6% | — | — | — |
| Résultat net | $-137M | $-166M | $-292M | $-237M | $-159M |
| BPA dilué | $-1.91 | $-2.33 | $-4.47 | $-4.48 | $-3.72 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 6.9 | 7.3 | 7.2 | 8.0 | — |
| Ratio de liquidité réduite | 1.0 | 0.7 | 0.4 | 0.8 | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-125M | $-171M | $-208M | $-166M | — |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.